At day 30, both 143B and HCT CI-deficient xenografts harbored more CD45 + cells than their CI-competent counterparts (Supplementary Fig. 11b), identifying immune cells abundance as a phenomenon shared in the CI-deficient tumor microenvironment. Here, PTPRC is linked to neoplasm.